Inventurus Knowledge Solutions Limited (NSE:IKS)
India
· Delayed Price · Currency is INR 1,305.20
-24.00 (-1.81%)
At close: Mar 9, 2026
NSE:IKS Revenue
Inventurus Knowledge Solutions had revenue of 8.15B INR in the quarter ending December 31, 2025, with 24.01% growth. This brings the company's revenue in the last twelve months to 30.60B, up 19.53% year-over-year. In the fiscal year ending March 31, 2025, Inventurus Knowledge Solutions had annual revenue of 26.64B with 46.54% growth.
Revenue (ttm)
30.60B
Revenue Growth
+19.53%
P/S Ratio
7.32
Revenue / Employee
4.06M
Employees
7,530
Market Cap
223.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.64B | 8.46B | 46.54% |
| Mar 31, 2024 | 18.18B | 7.87B | 76.28% |
| Mar 31, 2023 | 10.31B | 2.68B | 35.05% |
| Mar 31, 2022 | 7.64B | 2.11B | 38.20% |
| Mar 31, 2021 | 5.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Divi's Laboratories | 103.14B |
| Apollo Hospitals Enterprise | 242.15B |
| Cipla | 279.67B |
| Gland Pharma | 61.13B |
| Emcure Pharmaceuticals | 88.50B |
| Dr. Lal PathLabs | 26.63B |
| Pfizer | 24.82B |